Crossmark

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

Crossref DOI link: https://doi.org/10.15252/emmm.202013545

Published Online: 2021-01-21

Published Print: 2021-03-05

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Vavassori, Valentina

Mercuri, Elisabetta

Marcovecchio, Genni E

Castiello, Maria C

Schiroli, Giulia

Albano, Luisa

Margulies, Carrie

Buquicchio, Frank

Fontana, Elena

Beretta, Stefano

Merelli, Ivan

Cappelleri, Andrea

Rancoita, Paola MV

Lougaris, Vassilios

Plebani, Alessandro

Kanariou, Maria

Lankester, Arjan

Ferrua, Francesca

Scanziani, Eugenio

Cotta‐Ramusino, Cecilia

Villa, Anna

Naldini, Luigi https://orcid.org/0000-0002-7835-527X
Genovese, Pietro https://orcid.org/0000-0001-9507-9003
Funding

Funding for this research was provided by:

Fondazione Telethon (TIGET‐E3)

Ministero della Salute (GR‐2013‐02358956, GR‐2016‐02364847, PE‐2016‐02363691, E‐Rare‐3 JTC 2017)

Banca d'Italia

Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017 Prot. 20175XHBPN)

Louis-Jeantet Foundation
License Information

Version of Record valid from 2021-01-21
More Information

Publication History

Received: 2020-10-06

Accepted: 2020-12-10

Published: 2021-01-21